Novaliq GmbH

Novaliq GmbH is a company in Heidelberg, Germany that has taken part in 2 EU-funded projects since 2016, receiving €149k in EU funding.

EU funding received€149k
EU projects2
As coordinator0
Running now0
First EU project2016
Latest project2018
CountryGermany
EU registration (PIC)931266446
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Novaliq GmbH's own share of each project, not the project's full budget.

  • Horizon 2020€149k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • IT-DED3Partner

    Integrated Training in Dry Eye Disease Drug Development (IT-DED3)

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

  • ARREST BLINDNESSPartner

    Advanced Regenerative and REStorative Therapies to combat corneal BLINDNESS

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €149ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • confocal microscopy
  • drug discovery
  • gene therapy
  • medicinal chemistry
  • ophthalmology
  • pharmaceutical drugs
  • pharmacokinetics
  • stem cells
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime